Tarbox Family Office, Inc. Myovant Sciences Ltd. Transaction History

Tarbox Family Office, Inc.

  • $609 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022
BUY
$7.78 - $14.69 $213,950 - $403,975
27,500 New
27,500 $342,000
Q4 2021

Jan 06, 2022
SELL
$14.31 - $23.87 $393,525 - $656,425
-27,500 Closed
0 $0
Q3 2021

Oct 12, 2021
SELL
$18.94 - $26.99 $275,387 - $392,434
-14,540 Reduced 34.59%
27,500 $617,000
Q2 2021

Jul 16, 2021
BUY
$17.07 - $24.56 $717,622 - $1.03 Million
42,040 New
42,040 $957,000

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Tarbox Family Office, Inc. Portfolio

Follow Tarbox Family Office, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tarbox Family Office, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email